Ping An Biomedical (PASW) Ratios

16 Followers

Ping An Biomedical Ratios

See a summary of PASW’s cash flow.

Ratios	Sep 25	Sep 24	Sep 23	Sep 22
Liquidity Ratios
Current Ratio	―	2.76	0.84	0.89	1.02
Quick Ratio	―	2.74	0.84	0.86	0.96
Cash Ratio	―	0.05	<0.01	<0.01	0.02
Solvency Ratio	―	-0.55	-0.01	>-0.01	0.10
Operating Cash Flow Ratio	―	-0.28	0.23	-0.07	0.27
Short-Term Operating Cash Flow Coverage	―	-0.64	1.46	-0.14	0.59
Net Current Asset Value	¥ ―	¥ 40.52M	¥ -10.73M	¥ -9.13M	¥ 1.69M
Leverage Ratios
Debt-to-Assets Ratio	―	0.15	0.19	0.54	0.43
Debt-to-Equity Ratio	―	0.23	-1.50	-7.33	7.73
Debt-to-Capital Ratio	―	0.19	2.98	1.16	0.89
Long-Term Debt-to-Capital Ratio	―	0.00	0.00	0.00	0.00
Financial Leverage Ratio	―	1.51	-7.91	-13.63	17.82
Debt Service Coverage Ratio	―	-1.21	-0.01	0.03	0.25
Interest Coverage Ratio	―	-47.88	>-0.01	0.35	6.90
Debt to Market Cap	―	0.00	0.00	0.24	0.21
Interest Debt Per Share	―	0.00	0.00	2.18	1.81
Net Debt to EBITDA	―	-0.65	22.57	19.27	2.96
Profitability Margins
Gross Profit Margin	―	2.78%	6.18%	5.14%	12.35%
EBIT Margin	―	-42.10%	0.03%	2.16%	9.77%
EBITDA Margin	―	-42.09%	0.54%	2.66%	10.13%
Operating Profit Margin	―	-43.05%	>-0.01%	0.74%	9.44%
Pretax Profit Margin	―	-43.00%	-0.78%	0.05%	8.40%
Net Profit Margin	―	-37.57%	-1.47%	-1.20%	6.31%
Continuous Operations Profit Margin	―	-37.57%	-1.47%	-1.20%	6.31%
Net Income Per EBT	―	87.36%	188.10%	-2384.34%	75.08%
EBT Per EBIT	―	99.89%	33482.88%	6.81%	89.00%
Return on Assets (ROA)	―	-18.75%	-2.26%	-1.24%	8.82%
Return on Equity (ROE)	―	-28.36%	17.87%	16.96%	157.12%
Return on Capital Employed (ROCE)	―	-32.43%	0.03%	-10.57%	235.13%
Return on Invested Capital (ROIC)	―	-23.05%	-0.06%	-39.37%	20.22%
Return on Tangible Assets	―	-18.75%	-2.26%	-1.24%	8.82%
Earnings Yield	―	0.00%	0.00%	-0.56%	4.20%
Efficiency Ratios
Receivables Turnover	―	1.98	2.16	1.35	1.70
Payables Turnover	―	3.53	5.46	8.45	5.57
Inventory Turnover	―	75.13	645.78	24.56	21.70
Fixed Asset Turnover	―	73.03	107.20	153.00	627.38
Asset Turnover	―	0.50	1.54	1.03	1.40
Working Capital Turnover Ratio	―	2.25	-9.07	-22.41	-62.85
Cash Conversion Cycle	―	85.70	102.50	241.56	166.52
Days of Sales Outstanding	―	184.33	168.79	269.91	215.27
Days of Inventory Outstanding	―	4.86	0.57	14.86	16.82
Days of Payables Outstanding	―	103.50	66.85	43.21	65.56
Operating Cycle	―	189.19	169.35	284.77	232.08
Cash Flow Ratios
Operating Cash Flow Per Share	―	0.00	0.00	-0.30	1.03
Free Cash Flow Per Share	―	0.00	0.00	-0.30	1.03
CapEx Per Share	―	0.00	0.00	0.00	<0.01
Free Cash Flow to Operating Cash Flow	―	1.00	1.00	1.00	1.00
Dividend Paid and CapEx Coverage Ratio	―	0.00	45.38	-0.63	4.34
Capital Expenditure Coverage Ratio	―	0.00	0.00	0.00	851.05
Operating Cash Flow Coverage Ratio	―	-0.61	1.35	-0.14	0.59
Operating Cash Flow to Sales Ratio	―	-0.19	0.17	-0.07	0.18
Free Cash Flow Yield	―	0.00%	0.00%	-3.44%	12.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	0.00	0.00	-177.68	23.81
Price-to-Sales (P/S) Ratio	―	0.00	0.00	2.14	1.50
Price-to-Book (P/B) Ratio	―	0.00	0.00	-30.14	37.41
Price-to-Free Cash Flow (P/FCF) Ratio	―	0.00	0.00	-29.03	8.17
Price-to-Operating Cash Flow Ratio	―	0.00	0.00	-29.03	8.16
Price-to-Earnings Growth (PEG) Ratio	―	0.00	0.00	1.56	-3.02
Price-to-Fair Value	―	0.00	0.00	-30.14	37.41
Enterprise Value Multiple	―	-0.65	22.57	99.59	17.79
Enterprise Value	―	9.30M	10.68M	218.96M	206.48M
EV to EBITDA	―	-0.65	22.57	99.59	17.79
EV to Sales	―	0.27	0.12	2.65	1.80
EV to Free Cash Flow	―	-1.45	0.73	-36.00	9.80
EV to Operating Cash Flow	―	-1.45	0.73	-36.00	9.79
Tangible Book Value Per Share	―	0.00	0.00	-0.29	0.22
Shareholders’ Equity Per Share	―	0.00	0.00	-0.29	0.22
Tax and Other Ratios
Effective Tax Rate	―	0.13	-0.88	24.84	0.25
Revenue Per Share	―	0.00	0.00	4.03	5.59
Net Income Per Share	―	0.00	0.00	-0.05	0.35
Tax Burden	―	0.87	1.88	-23.84	0.75
Interest Burden	―	1.02	-30.27	0.02	0.86
Research & Development to Revenue	―	0.00	0.00	0.00	0.00
SG&A to Revenue	―	0.18	0.05	0.03	0.02
Stock-Based Compensation to Revenue	―	0.00	0.00	0.00	0.00
Income Quality	―	0.50	-11.39	6.12	2.92

Currency in CNY